Rezolute, Inc. (RZLT)
NASDAQ: RZLT · IEX Real-Time Price · USD
2.550
+0.310 (13.84%)
At close: Mar 28, 2024, 4:00 PM
2.600
+0.050 (1.96%)
After-hours: Mar 28, 2024, 7:16 PM EDT
Rezolute Market Cap
Rezolute has a market cap or net worth of $101.04 million as of March 28, 2024. Its market cap has increased by 33.13% in one year.
Market Cap
101.04M
Enterprise Value
10.96M
1-Year Change
33.13%
Ranking
Category
Stock Price
$2.55
Market Cap Chart
Since November 10, 2020, Rezolute's market cap has decreased from $167.00M to $101.04M, a decrease of -39.49%. That is a compound annual growth rate of -13.81%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Mar 28, 2024 | 101.00M | 13.74% |
Mar 27, 2024 | 88.80M | 5.71% |
Mar 26, 2024 | 84.00M | 12.15% |
Mar 25, 2024 | 74.90M | -5.55% |
Mar 22, 2024 | 79.30M | 4.20% |
Mar 21, 2024 | 76.10M | 0.53% |
Mar 20, 2024 | 75.70M | 0.53% |
Mar 19, 2024 | 75.30M | 6.21% |
Mar 18, 2024 | 70.90M | 0.57% |
Mar 15, 2024 | 70.50M | -2.22% |
Mar 14, 2024 | 72.10M | -5.26% |
Mar 13, 2024 | 76.10M | -1.55% |
Mar 12, 2024 | 77.30M | -2.52% |
Mar 11, 2024 | 79.30M | 5.31% |
Mar 8, 2024 | 75.30M | 5.02% |
Mar 7, 2024 | 71.70M | 0.84% |
Mar 6, 2024 | 71.10M | 0.85% |
Mar 5, 2024 | 70.50M | -7.36% |
Mar 4, 2024 | 76.10M | 6.73% |
Mar 1, 2024 | 71.30M | 9.02% |
Feb 29, 2024 | 65.40M | 1.87% |
Feb 28, 2024 | 64.20M | -4.18% |
Feb 27, 2024 | 67.00M | 3.08% |
Feb 26, 2024 | 65.00M | -4.69% |
Feb 23, 2024 | 68.20M | 7.57% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Connect Biopharma Holdings | 88.67M |
Aclaris Therapeutics | 88.66M |
Chimerix | 88.32M |
BioXcel Therapeutics | 88.06M |
111, Inc. | 84.83M |
Precision BioSciences | 83.69M |
Cue Biopharma | 83.03M |
PMV Pharmaceuticals | 82.88M |